Gyon Technologies Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-5,431
| Closed | -$1.51M | – | 400 |
|
2022
Q4 | $1.51M | Sell |
5,431
-7,994
| -60% | -$2.22M | 0.57% | 56 |
|
2022
Q3 | $2.81M | Buy |
13,425
+7,908
| +143% | +$1.66M | 0.88% | 30 |
|
2022
Q2 | $1.3M | Buy |
5,517
+2,472
| +81% | +$582K | 0.36% | 89 |
|
2022
Q1 | $546K | Sell |
3,045
-2,196
| -42% | -$394K | 0.38% | 90 |
|
2021
Q4 | $1.13M | Sell |
5,241
-11,181
| -68% | -$2.41M | 0.21% | 140 |
|
2021
Q3 | $3.03M | Buy |
16,422
+4,588
| +39% | +$847K | 0.82% | 23 |
|
2021
Q2 | $2.12M | Buy |
11,834
+6,383
| +117% | +$1.15M | 0.7% | 38 |
|
2021
Q1 | $912K | Sell |
5,451
-25,482
| -82% | -$4.26M | 0.4% | 62 |
|
2020
Q4 | $4.7M | Buy |
30,933
+23,397
| +310% | +$3.55M | 1.61% | 3 |
|
2020
Q3 | $761K | Buy |
+7,536
| New | +$761K | 0.6% | 43 |
|
2020
Q1 | – | Sell |
-11,186
| Closed | -$985K | – | 188 |
|
2019
Q4 | $985K | Buy |
+11,186
| New | +$985K | 0.65% | 55 |
|